Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 7, 1996, Pages 878-882

  Wilcken, David E L ^a,b   Wang, Xing L ^a   Sim, Ah Siew ^a   Michael McCredie, R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE HENRY HOSPITAL   (Australia)

Author keywords

body mass index; coronary artery disease; hyperhomocyst(e)inemia; methylenetetrahydrofolate reductase gene; thermolabile MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; ATHEROGENESIS; BODY MASS; CORONARY ARTERY DISEASE; FEMALE; GENE LOCUS; HOMOCYSTINURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLATION; POINT MUTATION; PRIORITY JOURNAL; TISSUE DISTRIBUTION; VASCULAR DISEASE;

EID: 0030057401     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.7.878     Document Type: Article

References (32)

1. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest. 1976;57:1079-1082.
2. Wilcken DEL, Reddy GSR, Gupta VJ. Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria. Metabolism. 1983;32:363-370.
3. Dudman NPB, Wilcken DEL, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease: its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb. 1993;13:1253-1260.
4. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-1155.
5. Wilcken DEL, Dudman NPB. Homocystinuria and atherosclerosis. In: Lusis AJ, Rother JI, Sparkes RS, eds. Molecular Genetics of Coronary Artery Disease: Candidate Genes and Processes in Atherosclerosis. Basel, Switzerland: Karger; 1992;14:311-324.
6. Boers GHJ, Smals AHG, Trijbels FJM, Trijbels FTM, Bakkeren TATM, Schoonderwaldt HC, Fowler B, Kleijer WT. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med. 1985;313:709-715.
7. Genest JJ Jr, McNamara JR, Salem DN, Wilson PFW, Upson B. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol. 1990;16:1114-1119.
8. Brattstrom L, Israelsson B, Norrving B, Bergqvist D, Thorne J, Hultberg B, Hamfelt A. Impaired homoeysteine metabolism in early onset cerebral and peripheral occlusive vascular disease: effects of pyridoxine and folic acid treatment. Atherosclerosis. 1990;81:51-60.
9. den Heijer M, Blom HJ, Gerrits WB, Rosendaal FR, Haak HL, Wijermans PW. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet. 1995;345:882-885.
10. Wilcken DEL, Gupta VJ, Betts AK. Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism. Clin Sci. 1981;61:743-749.
11. Wilcken DEL, Dudman NPB, Tyrrell PA, Robertson MR. Folic acid lowers elevated plasma homocyst(e)ine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism. 1988;37:697-701.
12. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homoeysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049-1057.
13. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw-Hill International Book Co; 1995:1279-1326.
14. Avramopoulos D, Cox T, Kraus JP, Chakravarti A, Antonarakis SE, Linkage mapping of the cystathionine β-synthase (CBS) gene on human chromosome 21 using a DNA polymorphism in the 3′ untranslated region. Hum Genet. 1993;90:566-568.
15. Goyette P, Sumner JS, Milos R, Duncan AMV, Rosenblatt DS, Mathews RG, Rozen R. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Gen. 1994;7:195-200.
16. Kraus JP. Molecular basis of phenotype expression in homocystinuria. J Inherit Metab Dis. 1994;17:383-390.
17. Hu FL, Gu Z, Kozich V, Kraus JP, Ramesh V, Shin VE. Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet. 1993;2:1857-1860.
18. Kozich V, Kraus JP. Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine beta-synthase deficiency. Hum Mutat. 1992;1:113-123.
19. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahy-drofolate reductase. Nat Genet. 1995;10:111-113.
20. Goyette P, Frosst P, Rosenblatt DS, Rozen R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet. 1995;56:1052-1059.
21. Kang SS, Wong PWK, Bock HG, Horwitz A, Grix A. Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Hum Genet. 1991;38:546-551.
22. Kang SS, Wong PWK, Susmano A, Sora H, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet. 1991;48:536-545.
23. Kang SS, Passen EL, Ruggie N, Wong PW, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 1993;88:1463-1469.
24. van der Put NM, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman ECM, den Heyer M, Rozen R, Blom HJ. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995;346:1070-1071.
25. Wilcken DEL, Wang XL, Greenwood J, Lynch J. Lipoprotein(a) and apolipoprotein B and A-I in children and coronary vascular events in their grandparents. J Pediatr. 1993;123:519-526.
26. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
27. Brandt PW, Partridge JB, Wattie JW. Coronary arteriography: method of presentation of the arteriogram report and scoring system. Clin Radiol. 1977;28:361-365.
28. Wang XL, Tam C, McCredie RM, Wilcken DEL. Determinants of severity of coronary artery disease in Australian men and women. Circulation. 1994;89:1974-1981.
29. Emery AEH. Hardy-Weinberg equilibrium: the estimation of gene frequencies. In: Emery AEH, ed. Methodology in Medical Genetics: An Introduction to Statistical Methods. Edinburgh, Scotland: Churchill Livingstone; 1976:3-9.
30. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extra-cranial carotid-artery stenosis. N Engl J Med. 1995;332:286-291.
31. Stampfer MJ, Malinow R, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877-881.
32. Hegele RA, Brunt JH, Connelly PW. Genetic variation on chromosome 1 associated with variation in body fat distribution in men. Circulation. 1995;92:1089-1093.